Does Renin-Angiotensin Aldosterone System Blockade Exacerbate Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease? A Prospective 50-month Mayo Clinic Study

By Onuigbo Macaulay   Onuigbo Nnonyelum  

Renal Failure, Vol. 30, Iss. 1, 2008-01 ,pp. : 67-72

Informa Healthcare

Access to resources Recommend Favorite

Morbid Obesity, Hypertensive Disease and the Renin-Angiotensin-Aldosterone Axis

By Rodríguez A   Ruano M   Silvestre V   Castro R   García-Lescún M   Marco A   García-Blanch G  

Obesity Surgery, Vol. 15, Iss. 5, 2005-05 ,pp. : 670-676

Springer Publishing Company

Access to resources Recommend Favorite

Antifibrotic Effects of Aldosterone Receptor Blocker (Spironolactone) in Patients with Chronic Kidney Disease

By Guney Ibrahim   Selcuk N. Yilmaz   Altintepe Lutfullah   Atalay Huseyin   Başarali M. Kemal   Büyükbaş Sadik  

Renal Failure, Vol. 31, Iss. 9, 2009-10 ,pp. : 779-784

Informa Healthcare

Access to resources Recommend Favorite

The Lack of Benefit of a Combination of an Angiotensin Receptor Blocker and Calcium Channel Blocker on Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease

By Oguzhan Nilufer   Cilan Havva   Sipahioglu Murat   Unal Aydin   Kocyigit Ismail   Kavuncuoglu Feridun   Arikan Tamer   Akpek Mahmut   Elcik Deniz   Sahin Omer   Gulme Ebru   Pala Cigdem   Tokgoz Bulent   Utas Cengiz   Oguzhan Abdurrahman   Oymak Oktay  

Renal Failure, Vol. 35, Iss. 4, 2013-05 ,pp. : 434-439

Informa Healthcare

Access to resources Recommend Favorite

Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome

By Nagase Miki  

Clinical and Experimental Nephrology, Vol. 14, Iss. 4, 2010-08 ,pp. : 303-314

Springer Publishing Company

Access to resources Recommend Favorite